Production (Stage)
Longevity Health Holdings, Inc.
XAGE
$2.38
-$1.07-31.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.50K | 20.50K | 12.30K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.50K | 20.50K | 12.30K | -- | -- |
| Cost of Revenue | 1.20K | 4.80K | 300.00 | -- | -- |
| Gross Profit | 16.30K | 15.70K | 12.00K | -- | -- |
| SG&A Expenses | 815.70K | 1.09M | 1.08M | 927.40K | 967.10K |
| Depreciation & Amortization | 18.40K | 18.00K | 23.50K | 23.50K | 23.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.02M | 1.44M | 1.20M | 1.38M | 333.00K |
| Operating Income | -1.01M | -1.42M | -1.19M | -1.38M | -333.00K |
| Income Before Tax | -1.01M | -2.88M | -3.30M | -3.55M | -8.90K |
| Income Tax Expenses | -97.30K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -914.30K | -2.88M | -3.30M | -3.55M | -8.90K |
| Earnings from Discontinued Operations | 0.00 | -- | -- | 282.20K | 3.17M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -914.30K | -2.88M | -3.30M | -3.27M | 3.16M |
| EBIT | -1.01M | -1.42M | -1.19M | -1.38M | -333.00K |
| EBITDA | -988.40K | -1.40M | -1.17M | -1.36M | -309.40K |
| EPS Basic | -1.31 | -4.13 | -4.78 | -4.28 | 4.04 |
| Normalized Basic EPS | -0.91 | -2.54 | -2.99 | -2.91 | -0.01 |
| EPS Diluted | -1.31 | -4.13 | -4.78 | -4.28 | 4.04 |
| Normalized Diluted EPS | -0.91 | -2.54 | -2.99 | -2.91 | -0.01 |
| Average Basic Shares Outstanding | 696.70K | 696.80K | 691.20K | 763.80K | 782.40K |
| Average Diluted Shares Outstanding | 696.70K | 696.80K | 691.20K | 763.80K | 782.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |